Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2 Study of UC-MSC Treatment for the Evaluation the Efficacy and Safety in Patients With Liver Cirrhosis

NCT01220492 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.

NCT NCT01220492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01220492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2 Study of UC-MSC Treatment for the Evaluation the Efficacy and Safety in Patients With Liver Cirrhosis
Lead sponsor
Beijing 302 Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2009
Completion date
April 30, 2016
Enrollment
266 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis